J&J dumps a failed PhIII antibiotic program picked up in Actelion buyout

J&J dumps a failed PhIII antibiotic program picked up in Actelion buyout

Source: 
Endpoints
snippet: 

J&J is washing its hands of the Phase III Clostridium difficile-associated diarrhea program for the antibiotic cadazolid.